What is Drug-eluting Coronary Stents - Global Market?
Drug-eluting coronary stents are a significant advancement in the treatment of coronary artery disease. These stents are small, expandable tubes inserted into the coronary arteries that supply blood to the heart. They are coated with medication that helps prevent the artery from becoming blocked again, a common issue known as restenosis. The global market for these stents is growing due to the increasing prevalence of cardiovascular diseases, advancements in medical technology, and a rising geriatric population. In 2023, the market was valued at approximately US$ 1,745.6 million and is projected to reach around US$ 2,363.2 million by 2030, with a compound annual growth rate (CAGR) of 4.2% from 2024 to 2030. This growth is driven by the demand for minimally invasive procedures and the effectiveness of drug-eluting stents in reducing the need for repeat interventions. As healthcare systems worldwide continue to focus on improving patient outcomes and reducing healthcare costs, the adoption of drug-eluting coronary stents is expected to rise, making them a crucial component in the management of coronary artery disease.
Stent Diameter ＜4mm, Stent Diameter ＞4mm in the Drug-eluting Coronary Stents - Global Market:
When discussing drug-eluting coronary stents, the diameter of the stent plays a crucial role in its application and effectiveness. Stents with a diameter of less than 4mm are typically used in smaller arteries. These smaller stents are essential for treating blockages in narrower vessels, which are often found in patients with smaller body sizes or specific anatomical considerations. The precision required for placing these stents is high, as the smaller diameter necessitates careful navigation through the vascular system to ensure proper placement and expansion. On the other hand, stents with a diameter greater than 4mm are used in larger arteries. These larger stents are crucial for treating blockages in wider vessels, which can accommodate a bigger stent size. The choice between these two sizes depends on the specific needs of the patient, the location of the blockage, and the size of the artery being treated. The global market for drug-eluting coronary stents is influenced by the demand for both sizes, as they cater to different patient demographics and medical conditions. The versatility in stent sizes allows for personalized treatment plans, improving patient outcomes and reducing the risk of complications. As the global population ages and the prevalence of cardiovascular diseases increases, the demand for both small and large diameter stents is expected to grow. This growth is supported by ongoing research and development efforts aimed at improving stent technology, including the development of new materials and drug coatings that enhance the performance and safety of these medical devices. The market for drug-eluting coronary stents is also driven by the increasing adoption of minimally invasive procedures, which offer faster recovery times and reduced hospital stays compared to traditional surgical methods. As healthcare providers continue to seek ways to improve patient care and reduce costs, the use of drug-eluting stents is likely to become more widespread. This trend is further supported by the growing awareness of the benefits of early intervention in the treatment of coronary artery disease, which can prevent more severe complications and improve long-term health outcomes. In summary, the global market for drug-eluting coronary stents is characterized by a diverse range of products that cater to different patient needs and medical conditions. The availability of stents in various sizes allows for tailored treatment approaches, enhancing the effectiveness of coronary interventions and contributing to the overall growth of the market.
ASCs, Hospitals, Cardiology Center, Others in the Drug-eluting Coronary Stents - Global Market:
Drug-eluting coronary stents are utilized in various healthcare settings, each playing a vital role in the treatment of coronary artery disease. Ambulatory Surgery Centers (ASCs) are increasingly adopting these stents due to their ability to perform minimally invasive procedures that allow patients to return home the same day. The use of drug-eluting stents in ASCs is driven by the need for cost-effective solutions that reduce hospital stays and improve patient satisfaction. Hospitals, on the other hand, remain the primary setting for the use of drug-eluting coronary stents. They offer comprehensive care, including advanced diagnostic and imaging technologies that aid in the precise placement of stents. Hospitals also provide the necessary infrastructure for managing complex cases and potential complications, making them a preferred choice for high-risk patients. Cardiology centers specialize in the treatment of heart-related conditions and are equipped with the expertise and technology required for the effective use of drug-eluting stents. These centers focus on providing specialized care, often collaborating with hospitals and ASCs to ensure continuity of care for patients. The use of drug-eluting stents in cardiology centers is driven by the need for specialized interventions that improve patient outcomes and reduce the risk of restenosis. Other healthcare settings, such as outpatient clinics and private practices, also contribute to the global market for drug-eluting coronary stents. These settings often cater to patients seeking convenient and personalized care, offering a range of services that include diagnostic evaluations and follow-up care. The use of drug-eluting stents in these settings is supported by advancements in telemedicine and remote monitoring technologies, which enable healthcare providers to manage patient care more effectively. Overall, the usage of drug-eluting coronary stents across different healthcare settings reflects the growing demand for effective and efficient treatment options for coronary artery disease. As healthcare systems continue to evolve, the adoption of these stents is expected to increase, driven by the need for improved patient outcomes and cost-effective solutions.
Drug-eluting Coronary Stents - Global Market Outlook:
The market outlook for drug-eluting coronary stents highlights their importance in reducing the risk of artery re-blockage. These stents are coated with medication that helps prevent restenosis, a common issue after angioplasty procedures. In 2023, the global market for drug-eluting coronary stents was valued at approximately US$ 1,745.6 million. It is projected to grow to around US$ 2,363.2 million by 2030, with a compound annual growth rate (CAGR) of 4.2% from 2024 to 2030. This growth is indicative of the increasing demand for effective cardiovascular treatments and the advancements in stent technology. In comparison, the global pharmaceutical market was valued at US$ 1,475 billion in 2022, with a projected CAGR of 5% over the next six years. The chemical drug market, on the other hand, was estimated to grow from US$ 1,005 billion in 2018 to US$ 1,094 billion in 2022. These figures highlight the significant role that drug-eluting coronary stents play within the broader pharmaceutical and medical device markets. As healthcare systems worldwide continue to prioritize patient outcomes and cost-effective solutions, the demand for drug-eluting stents is expected to rise, contributing to the overall growth of the market.
| Report Metric | Details |
| Report Name | Drug-eluting Coronary Stents - Market |
| Forecasted market size in 2030 | US$ 2363.2 million |
| CAGR | 4.2% |
| Forecasted years | 2024 - 2030 |
| Segment by Type: |
|
| Segment by Application |
|
| By Region |
|
| By Company | Medtronic, Boston Scientific, Biosensors, Terumo, MicroPort, Lepu Medical, B.Braun, Atrium Medical, SINOMED, LBC, Essen Technology |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
